Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Nusep Holdings Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nusep Holdings Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nutra Pharma Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nutra Pharma Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nutraplus India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nutraplus India Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nuvo Research Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nuvo Research Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Nymox Pharmaceutical Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Nymox Pharmaceutical Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oasmia Pharmaceutical AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oasmia Pharmaceutical AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Obagi Medical Products, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Obagi Medical Products, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OBJ Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OBJ Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ocean Bright Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ocean Bright Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OctoPlus N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OctoPlus N.V. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Sonoma Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Sonoma Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ohr Pharmaceutical, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ohr Pharmaceutical, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OJSC Pharmstandard Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OJSC Pharmstandard Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Olfactory Biosciences Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Olfactory Biosciences Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Omeros Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Omeros Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Omni Bio Pharmaceutical, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Omni Bio Pharmaceutical, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Omnimmune Holdings, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Omnimmune Holdings, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoGenex Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoGenex Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oncologix Tech, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oncologix Tech, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oncolytics Biotech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oncolytics Biotech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoTherapy Science Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoTherapy Science Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oncothyreon Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oncothyreon Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

OncoVista Innovative Therapies, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

OncoVista Innovative Therapies, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ondine Biomedical Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ondine Biomedical Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

One World Nutrition Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

One World Nutrition Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oneness Biotech Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oneness Biotech Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ono Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ono Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Onyx Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Onyx Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Acer Therapeutics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Acer Therapeutics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Opko Health, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Opko Health, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Optigenex Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Optigenex Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Optimer Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Optimer Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oragenics Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oragenics Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oramed Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oramed Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Orchid Cellmark Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Orchid Cellmark Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Orchid Pharma Ltd Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Orchid Pharma Ltd Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ore Pharmaceutical Holdings Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ore Pharmaceutical Holdings Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Orexigen Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Orexigen Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Orexo AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Orexo AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Orient Europharma Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Orient Europharma Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Origio a/s Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Origio a/s Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Orion Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Orion Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ortin Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ortin Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oscar Investments Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oscar Investments Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Oscotec Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Oscotec Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Osiris Therapeutics, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Osiris Therapeutics, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Osta Biotechnologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Osta Biotechnologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Osteologix, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Osteologix, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Otsuka Holdings Co., Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Otsuka Holdings Co., Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Otsuka Pakistan Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Otsuka Pakistan Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1